REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding, Issue of Equity, TVR

30 Nov 2022 14:44

RNS Number : 1219I
DX (Group) PLC
30 November 2022
 

AIM: DX.

DX (Group) plc

("DX", the "Company" or the "Group") 

 

Director/PDMR Shareholding, Issue of Equity and

Total Voting Rights

 

DX, the provider of delivery solutions, including parcel freight, secure courier and logistics services, announces that, on 28 November 2022, it received a notification of exercise from David Mulligan, Chief Financial Officer and a person discharging managerial responsibility of the Company ("PDMR"), in relation to 3,324,877 share options ("Options") over ordinary shares of 1p each in the Company ("Ordinary Shares") at an exercise price of 1.0 pence (the "Exercise") pursuant to the Company's Performance Share Plan 2017 (the "PSP").

 

The Company has determined to reduce the number of Ordinary Shares to be issued in respect of the Exercise equal to the tax liability that arises in connection with the Exercise ("Net Settlement"). The Exercise becomes an entitlement to receive a reduced number of Ordinary Shares (the "Adjusted Award") and a cash amount (the "Cash Amount") equal to the value of the number of Ordinary Shares by which the Options are reduced. The Company will then ensure that the Cash Amount is paid directly to HMRC to discharge the tax liability that arises as a result of the Exercise (with any surplus cash being returned to David Mulligan). Accordingly, David Mulligan will receive 1,694,407 Ordinary Shares as the Adjusted Award and £423,922 as the Cash Amount.

 

Following the Exercise, David Mulligan has a total beneficial shareholding of 4,163,348 Ordinary Shares, representing approximately 0.71% of the Company's enlarged issued share capital.

 

The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

 

Issue of Equity

 

In addition to David Mulligan, notifications of exercise have been received in relation to 2,527,749 Options from 6 other participants in the PSP.

 

Accordingly, following Net Settlement of these Options, application has been made for a total of 2,409,785 new Ordinary Shares to be issued to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 6 December 2022.

 

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company's issued share capital consists of 583,163,226 Ordinary Shares, each with voting rights. Accordingly, the figure of 583,163,226 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Following the Exercise, there are options outstanding over 69,025,144 Ordinary Shares, representing 11.84% of the Company's enlarged issued share capital.

 

Enquiries: 

DX (Group) plc

www.dxdelivery.com

Mark Hammond, Executive Chairman

David Mulligan, Chief Financial Officer

T: 020 3178 6378

(c/o KTZ Communications)

finnCap (Nominated Advisor and Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks (Corporate Finance)

Andrew Burdis/Charlotte Sutcliffe (Corporate Broking)

Liberum (Joint Broker to DX)

T: 020 3100 2000

Nick How/William Hall

KTZ Communications

Katie Tzouliadis/ Dan Mahoney

T: 020 3178 6378

 

About DX (Group) plc:

DX is a well-established provider of a wide range of delivery services to both business and residential addresses across the UK and Ireland. First established in 1975 as a Document Exchange service to the legal sector, DX now provides one of the widest ranges of overnight delivery services in the market, as well as logistics services. Items that DX transports range from confidential documents and valuable packages to large, awkward-to-handle freight, unsuitable for automated conveyor. 

 

DX Freight: comprises DX 1-Man, DX 2-Man and Logistics. The Division specialises in the delivery of irregular dimension and weight freight ("IDW"). 

 

DX Express: comprises DX Parcels and DX Exchange and Mail. The Division specialises in the express delivery of parcels and documents. 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

David Mulligan

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

PDMR

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

DX (Group) plc

b)

LEI:

213800LA2YGSOFIYIH95

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Options over Ordinary Shares of 1p

GB00BJTCG679

b)

Nature of the transaction:

Exercise of 3,324,877 Options over Ordinary Shares

c)

Price(s) and volume(s):

Net settled for cash:

Price(s) pence

Volume(s)

26.00

1,630,470

 

Issue of equity:

Price(s) pence

Volume(s)

1.00

1,694,407

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4 (c) above

e)

Date of the transaction:

28 November 2022

f)

Place of the transaction:

Off market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKKBNQBDDCDN
Date   Source Headline
30th Jan 20247:00 amRNSCancellation - DX (Group) PLC
29th Jan 20242:16 pmRNSForm 8.3 - DX (Group) plc
29th Jan 202410:54 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
29th Jan 202410:29 amRNSScheme Effective
29th Jan 20249:30 amRNSForm 8.5 (EPT/RI)
26th Jan 202412:06 pmRNSForm 8.3 - DX (Group) plc
26th Jan 202410:22 amRNSForm 8.5 (EPT/RI)
26th Jan 20247:00 amRNSRule 2.9 Announcement
25th Jan 20244:02 pmRNSForm 8.3 -DX GROUP PLC Amendment
25th Jan 20242:12 pmRNSForm 8.3 - DX (Group) plc
25th Jan 20241:03 pmRNSPDMR Dealings
25th Jan 202411:51 amRNSResults of Sanction Hearing
25th Jan 202410:14 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
24th Jan 202411:23 amRNSForm 8.5 (EPT/RI)
23rd Jan 20241:27 pmRNSUpdate on financing arrangements
23rd Jan 202410:43 amRNSForm 8.5 (EPT/RI)
22nd Jan 20242:03 pmRNSForm 8.3 - DX GROUP PLC
22nd Jan 202412:36 pmGNWForm 8.3 - DX (Group) Plc
22nd Jan 202411:09 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
22nd Jan 202411:02 amRNSForm 8.5 (EPT/RI)
19th Jan 20243:29 pmRNSForm 8.3 - DX Group Plc
19th Jan 20242:40 pmPRNForm 8.3 - DX (Group) Plc
19th Jan 202412:11 pmRNSForm 8.3 - DX GROUP PLC
19th Jan 202410:44 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
19th Jan 202410:12 amRNSForm 8.3 - DX (Group) Plc
19th Jan 20249:34 amRNSForm 8.5 (EPT/RI)
18th Jan 202412:52 pmRNSForm 8.3 - DX (Group) plc
18th Jan 20249:22 amRNSForm 8.5 (EPT/RI)
17th Jan 20242:35 pmRNSForm 8.3 - DX (Group) plc
17th Jan 202411:15 amRNSForm 8.5 (EPT/RI)
17th Jan 202410:16 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
16th Jan 20241:17 pmRNSForm 8.3 - DX (Group) plc
16th Jan 202411:47 amRNSForm 8.5 (EPT/RI)
15th Jan 202410:53 amRNSForm 8.5 (EPT/RI)
15th Jan 202410:00 amRNSForm 8.5 (EPT/RI) - DX (Group) Plc
12th Jan 20241:26 pmRNSForm 8.3 - DX (Group) plc
12th Jan 202411:28 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:44 amRNSForm 8.5 (EPT/RI) - DX (Group) Plc
11th Jan 202412:01 pmRNSHolding(s) in Company
11th Jan 20249:32 amRNSForm 8.5 (EPT/RI)
10th Jan 20241:46 pmRNSForm 8.3 - DX (Group) plc
10th Jan 202412:46 pmPRNForm 8.3 - DX (Group) Plc
10th Jan 20249:37 amRNSForm 8.5 (EPT/RI)
9th Jan 202412:40 pmRNSResults of Court Meeting and General Meeting
9th Jan 202412:24 pmPRNForm 8.3 - DX (Group) Plc
9th Jan 20249:29 amRNSForm 8.5 (EPT/RI)
8th Jan 20242:08 pmRNSForm 8.3 - DX (Group) plc
8th Jan 20241:37 pmRNSForm 8.3 - DX (Group) plc
8th Jan 20241:18 pmRNSForm 8.3 - DX (Group) Plc
8th Jan 20249:39 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.